This designation was based on the results from MONALEESA-7, presented just last month in San Antonio. Looking forward: MONALEESA-7 was a good look into how the CDK inhibitors are rapidly expanding their reach in the treatment of breast cancer. As such, I expect we are going to see a lot of…
News
- 3 Things In Biotech You Should Learn Today: January 4, 2018
- Novelty in science – real necessity or distracting obsession?
KOCO; San Antonio child sings 'Remember Me' from Coco in heart-wrenching... mysa; Well-known San Antonio cook gunned down on his front porch,... ... is that scientific papers now inflate their claims in order to emphasize their novelty and the relevance of biomedical research for clinical…
- U of Chicago cancer research program to include teachers
... underrepresented in science courses to study the subject. Minority, low-income and disabled students and those who are the first in their families to have a chance to attend college are paid for eight-week laboratory sessions for two consecutive summers. They conduct biomedical research…
- New Faces: Acelity CEO expanding global game plan
As an eventful year comes to a close, the San Antonio Business Journal takes stock of the high-profile hirings and promotions at the top of several prominent Alamo City companies and organizations in the 12/29 weekly edition. It's been an interesting year for Acelity LP as the San Antonio-based…
- New businesses lagging on the East Side
Cassie Kim, 42, who lives in one of the market-rate units at East Meadows, said she'd heard chat-board rumors to avoid the East Side when she was researching moving to San Antonio from Fort Gordon in Georgia. Kim, whose husband Jongman Kim, 37, is now a trainee in a biomedical equipment tech…